Zhangzhou Pientzehuang Pharmaceutical., Ltd

XSSC:600436 Stock Report

Market Cap: CN¥124.0b

Zhangzhou Pientzehuang Pharmaceutical Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Jin Ming Huang

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure5.5yrs
CEO ownershipn/a
Management average tenure5.5yrs
Board average tenure2.3yrs

Recent management updates

Recent updates

CEO

Jin Ming Huang (58 yo)

5.5yrs

Tenure

CN¥601,700

Compensation

Mr. Jin Ming Huang is GM & Director of Zhangzhou Pientzehuang Pharmaceutical., Ltd from July 2019. He joined the Zhangzhou Pientzehuang Pharmaceutical., Ltd in September 2006. Mr. Huang served as President...

Leadership Team

NamePositionTenureCompensationOwnership
Jin Ming Huang
GM & Director5.5yrsCN¥601.70kno data
Haipeng Yang
Chief Accountant & Director16.5yrsCN¥529.50kno data
Fei Hong
Chief Engineerno dataCN¥529.50kno data
Honghui Chen
Deputy GM2.4yrsno datano data

5.5yrs

Average Tenure

55.5yo

Average Age

Experienced Management: 600436's management team is seasoned and experienced (5.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Jin Ming Huang
GM & Director5.5yrsCN¥601.70kno data
Haipeng Yang
Chief Accountant & Directorno dataCN¥529.50kno data
Honghui Chen
Deputy GMno datano datano data
Dong Ming Hong
Directorno dataCN¥444.50kno data
Tengyun Wei
Supervisor3yrsno datano data
Shouying Du
Independent Director3yrsCN¥80.00kno data
Shibin Xu
Chairman of Supervisory Boardno datano datano data
Zhi Hui Lin
Chairman of the Boardno datano datano data
Wenning Lai
Non-independent Directorno datano datano data
Lei Zhang
Independent Director1.5yrsno datano data
Zhengda Tian
Independent Directorless than a yearno datano data
Lei Chen
Independent Director1.6yrsno datano data

2.3yrs

Average Tenure

52yo

Average Age

Experienced Board: 600436's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/09 21:42
End of Day Share Price 2025/01/09 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Zhangzhou Pientzehuang Pharmaceutical., Ltd is covered by 29 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sandra SunBofA Global Research
Siti Bte SalikinCFRA Equity Research
Shuchang LiuChangjiang Securities Co. LTD.